Rising Prevalence Of Genetic Disorders Growth In DNA Diagnostics: Transformative Forces Shaping the DNA Diagnostics Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the DNA Diagnostics Industry Market Size Be by 2025?
There has been a notable expansion in the DNA diagnostics market size in the past few years. It's expected to escalate from $23.1 billion in 2024 to $25.67 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. The surge during the historical period is credited to increased preference for personalized medicine, the growing acceptance of genetic testing and molecular diagnostics in clinical applications, the upswing in biomedical research, the rising number of cancer patients, and the advancement in the use of diagnostic tests.

What's the Long-Term Growth Forecast for the DNA Diagnostics Market Size Through 2029?
The market for DNA diagnostics is projected to experience a significant surge in growth over the coming years, growing to $38.64 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 10.8%. This growth during the forecast period can be associated with several factors such as the escalating prevalence of cancer, higher demand for uniform diagnostic examinations, increased incidence of genetic disorders, a stronger concentration on identifying biomarkers, rare illnesses and orphan drugs, and expansion of telemedicine and remote examinations. Some major trends to expect within this forecast period include the fusion of microbiome analysis, incorporation of blockchain technology, combination of various omics data, non-invasive testing methods, multiple omics integration, the invention of portable and on-spot DNA diagnostic appliances, and next-generation sequencing (NGS).

View the full report here:
https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

What Are the Key Growth Drivers Fueling the DNA Diagnostics Market Expansion?
Growth in the DNA diagnostics market is likely to be fueled by the increasing occurrence of genetic disorders. Health issues prompted by one or more anomalies in the genome are referred to as genetic disorders. Enhanced diagnostic abilities, broader genetic testing, environmental impacts, and intermarriage within demographic groups have all contributed to a surge in genetic disorders. As a result, there's improved understanding and recognition of these conditions. DNA diagnostics allow for precise identification of these disorders by analyzing genetic material, thereby enabling prompt diagnosis, personalized treatments and informed decisions regarding family planning. As per data from the World Health Organization (WHO) in February 2023, the specialized United Nations agency for global public health based in Switzerland, an estimated 240,000 newborns globally succumb to congenital diseases within 28 days of their birth every year, with a further 170,000 deaths in children aged between one month and five years due to these diseases. This rising occurrence of genetic disorders is therefore propelling the growth of the DNA diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15356&type=smp

What Are the Key Trends Driving DNA Diagnostics Market Growth?
Leading entities in the DNA diagnostics market are concentrating their efforts on creating novel products like liquid biopsy tests aimed at early detection of various forms of cancer. Liquid biopsies are non-invasive clinical examinations that trace and scrutinize biomarkers, including cell-free DNA (cfDNA), circulating tumor cells (CTCs), or exosomes, liberated into the blood circulation from tumors or other cells. For instance, Laboratory Corporation, a U.S.-based medical diagnostics firm, unveiled a new liquid biopsy test known as LabCorp Plasma Focus in May 2023. The test uses genetic sequencing to examine the circulating cell-free DNA (cfDNA) discharged by tumor cells. This helps oncologists to customize and enhance patient care with targeted therapy plans.

How Is the DNA Diagnostics Market Segmented?
The DNA diagnostics market covered in this report is segmented -

1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Polymerase Chain Reaction, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry
3) By Application: Oncology, Infectious Diseases Treatment, Myogenic Disorder Treatment, Clinical Diagnostic Confirmation, Prenatal, Pre-Implantation, Other Applications
4) By End User: Point Of Care, Diagnostic Centers, Self-Testing Or Over-The-Counter (OTC)

Subsegments
1) By Instruments: DNA Analyzers, PCR Machines (Polymerase Chain Reaction), Sequencers (Next-Generation Sequencing, Sanger Sequencing), Electrophoresis Systems, Gene Expression Analyzers, Microarray Systems, Flow Cytometers, Spectrophotometers
2) By Reagents: PCR Reagents, DNA Extraction Kits, Sequencing Reagents, Antibodies For DNADetection, Fluorescent Dyes And Probes, Chemicals For Nucleic Acid Purification, Buffer Solutions For DNA Analysis, Hybridization And Amplification Kits
3) By Software: DNA Data Analysis Software, Bioinformatics Platforms, Genomics Software For Sequencing Data, Laboratory Information Management Systems (LIMS), Data Visualization Tools, Genetic Variant Analysis Software, Genome Mapping Software
4) By Services: Genetic Testing Services, DNA Sequencing Services, Bioinformatics Consulting And Analysis, Clinical Diagnostic Services, Genetic Counseling Services, Custom DNA Diagnostics Services, Research And Development Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15356&type=smp

Which Companies Are Leading the Charge in DNA Diagnostics Market Innovation?
Major companies operating in the DNA diagnostics market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Veritas Genetics

Which Regions Are Leading the Global DNA Diagnostics Market in Revenue?
North America was the largest region in the DNA diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15356

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.